61494 Federal Register / Vol. 62, No. 222 / Tuesday, November 18, 1997 / Notices

with the Magnuson-Stevens Fishery

Conservation and Management Act,

those issues may not be the subject of

formal Council action during the

meeting. Council action will be

restricted to those issues specifically

identified in the agenda listed in this

notice.

Special Accommodations

These meetings are physically

accessible to people with disabilities.

Requests for sign language

interpretation or other auxiliary aids

should be directed to Helen Allen, 907–

271–2809, at least 5 working days prior

to the meeting date.

Dated: November 12, 1997.

Bruce C. Morehead,

Acting Director, Office of Sustainable

Fisheries, National Marine Fisheries Service.

[FR Doc. 97–30254 Filed 11–17–97; 8:45 am]

BILLING CODE 3510–22–F

DEPARTMENT OF COMMERCE

National Oceanic and Atmospheric

Administration

[I.D. 111297C]

Marine Mammals (File No. 758–1431)

AGENCY: National Marine Fisheries

Service (NMFS), National Oceanic and

Atmospheric Administration (NOAA),

Commerce.

ACTION: Issuance of scientific research

permit no. 758–1431.

SUMMARY: Notice is hereby given that Dr.

Kimberlee Beckmen, Institute of Arctic

Biology, University of Alaska Fairbanks,

P.O. Box 757000, Fairbanks, AK 99775–

7000, is hereby authorized to conduct

research on two captive, adult Northern

fur seals (Callinorinus ursinus).

ADDRESSES: The permit and related

documents are available for review

upon written request or by appointment

in the following offices:

Permits Division, Office of Protected

Resources, NMFS, 1315 East-West

Highway, Room 13130, Silver Spring,

MD 20910 (301/713–2289);

Regional Administrator, Northwest

Region, NMFS, NOAA, 7600 Sand Point

Way, NE., BIN C15700, Building 1,

Seattle, WA 98115–0070 (206/526–

6150);

Regional Administrator, Alaska

Region, NMFS, NOAA, P.O. Box 21668,

Juneau, AK 99802–1668 (907/586–

7221).

SUPPLEMENTARY INFORMATION: On

September 29, 1997, notice was

published in the Federal Register (62

FR 50907) that the above-named

applicant had submitted a request for a

scientific research permit to blood

sample and vaccinate two captive, adult

Northern fur seals with a benign

antigen, Fort Dodge tetanus toxoid, for

the purpose of scientific research at a

U.S. facility that is holding captive

Northern fur seals. The requested permit

has been issued under the authority of

the Marine Mammal Protection Act of

1972, as amended (16 U.S.C. 1361 et

seq.), the Fur Seal Act of 1966, as

amended (16 U.S.C. 1151 et seq.), and

the regulations governing the taking and

importing of marine mammals (50 CFR

Part 216).

Dated: November 12, 1997.

Ann D. Terbush,

Chief, Permits and Documentation Division,

Office of Protected Resources, National

Marine Fisheries Service.

[FR Doc. 97–30255 Filed 11–17–97; 8:45 am]

BILLING CODE 3510–22–F

DEPARTMENT OF COMMERCE

National Oceanic and Atmospheric

Administration

[I.D. 102497A]

Marine Mammals, Endangered or

Threatened Species, Scientific

Research Permit (File No. 473–1433);

Correction

AGENCY: National Marine Fisheries

Service (NMFS), National Oceanic and

Atmospheric Administration (NOAA),

Commerce.

ACTION: Receipt of application;

correction.

SUMMARY: The National Marine

Fisheries Service published a document

in the Federal Register of October 31,

1997, concerning an application to take

several species of cetaceans for purposes

of scientific research. The document

inadvertently omitted that the proposed

takes are to be conducted on an annual

basis.

FOR FURTHER INFORMATION CONTACT:

Jeannie Drevenak, Permits Division,

Office of Protected Resources, NMFS,

1315 East-West Highway, Room 13824,

Silver Spring, MD 20910 (301/713–

2289).

Correction

In the Federal Register issue of

October 31, 1997, in FR Doc. 97–28833,

on page 58943, in the first column,

correct the second paragraph under the

SUPPLEMENTARY INFORMATION caption by

inserting the word ‘‘annually’’ before

the word ‘‘from’’ in line four and the

word ‘‘annually’’ between the words

‘‘physalus’’ and ‘‘may’’ in line 17.

Dated: November 12, 1997.

Ann D. Terbush,

Chief, Permits and Documentation Division,

Office of Protected Resources, National

Marine Fisheries Service.

[FR Doc. 97–30159 Filed 11–17–97; 8:45 am]

BILLING CODE 3510–22–F

DEPARTMENT OF DEFENSE

Office of the Secretary

Civilian Health and Medical Program of

the Uniformed Services (CHAMPUS)

AGENCY: Office of the Secretary, DoD.

ACTION: Notice of extension of cancer

treatment clinical trails demonstration

project.

SUMMARY: This notice is to advise

interested parties of a one-year

extension of a demonstration project in

which the DoD provides CHAMPUS

reimbursement for eligible beneficiaries

who receive cancer treatment under

approved National Institutes of Health,

National Cancer Institute (NCI) clinical

trails. Participation in these clinical

trails will improve access to promising

cancer therapies for CHAMPUS eligible

beneficiaries when their conditions

meet protocol eligibility criteria. DoD

financing of these procedures will assist

in meeting clinical trail goals and arrival

at conclusions regarding the safety and

efficacy of emerging therapies in the

treatment of cancer. At this time, there

is insufficient demonstration data for a

full evaluation of costs associated with

enrollment in clinical trails. Extending

the demonstration for an additional year

will show sufficient time for patient

accrual to clinical trials and collection

of data which allows for comprehensive

economic analysis. This demonstration

also affects TRICARE, the managed

health care program that includes

CHAMPUS. This demonstration project

is under the authority of 10 U.S.C.,

section 1092.

EFFECTIVE DATE: January 1, 1998.

FOR FURTHER INFORMATION CONTACT:

Cynthia P. Speight, Office of the

Assistant Secretary of Defense (Health

Affairs), (703) 697–8975.

SUPPLEMENTARY INFORMATION:

Background

On January 24, 1996, the Department

provided notice in the Federal Register

(61 FR 1899) of an extension of an

existing demonstration for breast cancer

treatment clinical trials to include all

cancer treatment clinical trials under

approved National Cancer Institute

(NCI) clinical trials. The demonstration

purpose is to improve beneficiary access